Semler Scientific reached an agreement in principle with the U.S. Department of Justice to settle fraud claims for $29.75 million.
The settlement relates to a civil investigational demand issued by the Justice Department concerning alleged violations under the False Claims Act, according to a Form 8-K filed April 15.
While the deal is not finalized, Semler acknowledged that it may still need to secure agreement from HHS and undertake additional compliance obligations. If a final agreement cannot be reached, the department could still pursue litigation seeking damages exceeding the original proposed amount, according to the Form 8-K.
The company also reported a preliminary operating loss of up to $1.5 million for the first quarter of 2025 including $400,000 in legal costs tied to the DOJ investigation.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.